We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ImmunOs Therapeutics

News List

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients PharmaSources
May 05, 2023
April 12, 2023，ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002.
ImmunOs Uses ProBioGen’s Pathway Modulator Technology contractpharma
October 29, 2020
DirectedLuck transposase technology will be used to increase protein yield of selected candidates in their pipeline of complex recombinant proteins.
ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services prnasia
March 02, 2020
ProBioGen AG today announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics.